LeMaitre Vascular, Inc. - Common Stock (LMAT)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Mar 31, 2026Investment Snapshot
- Trading 254% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 13.5% — below-average profitability
- Revenue growing at 14% annually
LeMaitre Vascular, Inc. - Common Stock (LMAT) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $2.4 billion . Key value metrics: P/E ratio 45.7, P/B ratio 6.19, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
LeMaitre Vascular, Inc. - Common Stock — Fundamental Analysis Summary
LeMaitre Vascular, Inc. - Common Stock (LMAT) is currently trading 254% above its Graham Number of $30.16, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 45.7x.
On financial health, LMAT shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 13.5% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.56.
StockPik's composite Value Score for LMAT is 44/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
LMAT reports a high gross margin of 67.9% (sector average: 33.5%) and a strong operating margin of 24.9%.
LMAT shows revenue growing at 14% year-over-year, with earnings growing at 31%.
LMAT pays a modest dividend yield of 0.7%.